N
DAWN

Nuveen’s Day One Biopharmaceuticals DAWN Stock Holding History

Nuveen’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$39.1M Buy
1,823,998
+1,301,543
+249% +$18.3M 0.01% 763
2025
Q4 		$4.87M Buy
522,455
+372,083
+247% +$3.11M ﹤0.01% 1920
2025
Q3 		$1.06M Hold
150,372
– – ﹤0.01% 2601
2025
Q2 		$977K Buy
150,372
+10,714
+8% +$73.7K ﹤0.01% 2614
2025
Q1 		$1.11M Sell
139,658
-1,640
-1% -$17.7K ﹤0.01% 2594
2024
Q4 		$1.79M Sell
141,298
-22,400
-14% -$312K ﹤0.01% 2432
2024
Q3 		$2.28M Sell
163,698
-27,208
-14% -$388K ﹤0.01% 2346
2024
Q2 		$2.63M Buy
190,906
+15,131
+9% +$221K ﹤0.01% 2249
2024
Q1 		$2.9M Hold
175,775
– – ﹤0.01% 2229
2023
Q4 		$2.57M Sell
175,775
-249,434
-59% -$3.02M ﹤0.01% 2295
2023
Q3 		$5.22M Buy
425,209
+72,443
+21% +$945K ﹤0.01% 1846
2023
Q2 		$4.21M Sell
352,766
-146,025
-29% -$1.91M ﹤0.01% 2007
2023
Q1 		$6.67M Buy
498,791
+77,664
+18% +$1.52M ﹤0.01% 1727
2022
Q4 		$2.79M Sell
421,127
-27,643
-6% -$567K ﹤0.01% 2236
2022
Q3 		$2.97M Buy
448,770
+376,218
+519% +$8M ﹤0.01% 2183
2022
Q2 		$481K Buy
72,552
+32,778
+82% +$338K ﹤0.01% 3024
2022
Q1 		$391K Buy
39,774
+24,813
+166% +$328K ﹤0.01% 3072
2021
Q4 		$260K Hold
14,961
– – ﹤0.01% 3197
2021
Q3 		$355K Buy
+14,961
New +$359K ﹤0.01% 3227

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Nuveen's DAWN Position: Q1 2026 in Review

Nuveen increased its Day One Biopharmaceuticals (DAWN) stake by 249% in Q1 2026, buying an estimated $18.3M and bringing the position to 1,823,998 shares worth $39.1M. The position accounts for 0.01% of the portfolio, ranked #763.

Nuveen first reported a position in DAWN in Q3 2021 and has held it in 19 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Nuveen held 1,823,998 shares of Day One Biopharmaceuticals worth $39.1M as of Q1 2026.
  • Nuveen bought 1,301,543 Day One Biopharmaceuticals shares in Q1 2026, an estimated $18.3M.
  • Day One Biopharmaceuticals made up 0.01% of Nuveen's portfolio in Q1 2026, its #763 holding.
  • Nuveen first reported a position in Day One Biopharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.